Biomimetic Membranes as a Technology Platform: Challenges and Opportunities

Autor: Claus Hélix-Nielsen
Rok vydání: 2018
Předmět:
separation
Computer science
02 engineering and technology
Technology development
Water Treatment Techniques
lcsh:Chemical technology
01 natural sciences
Biomimetic membrane
Biomimetics
Energy-conversion
Chemical Engineering (miscellaneous)
Energy transformation
Water treatment
lcsh:TP1-1185
lcsh:Chemical engineering
sensing
Controlled drug delivery
Biomimetic processes
Targeted drug delivery
Aquaporin
Photovoltaic cells
lcsh:TP155-156
biomimetic
021001 nanoscience & nanotechnology
Scalability
Photoelectrochemical cells
Biomimetic
0210 nano-technology
Biotechnology
Electric Batteries
Biomimetic membranes
Functional components
Membrane technology
biomedicine
Filtration and Separation
Technology platforms
Mechanism of action
010402 general chemistry
Aquaporins
Chemical Operations
Separation
SDG 7 - Affordable and Clean Energy
Energy Conversion
Process Chemistry and Technology
Production cost
0104 chemical sciences
aquaporin
Biomedicine
energy-conversion
Sensing
Biochemical engineering
Zdroj: Membranes, Vol 8, Iss 3, p 44 (2018)
Hélix-Nielsen, C 2018, ' Biomimetic membranes as a technology platform: Challenges and opportunities ', Membranes, vol. 8, no. 3, 44 . https://doi.org/10.3390/membranes8030044
ISSN: 2077-0375
DOI: 10.3390/membranes8030044
Popis: Biomimetic membranes are attracting increased attention due to the huge potential of using biological functional components and processes as an inspirational basis for technology development. Indeed, this has led to several new membrane designs and applications. However, there are still a number of issues which need attention. Here, I will discuss three examples of biomimetic membrane developments within the areas of water treatment, energy conversion, and biomedicine with a focus on challenges and applicability. While the water treatment area has witnessed some progress in developing biomimetic membranes of which some are now commercially available, other areas are still far from being translated into technology. For energy conversion, there has been much focus on using bacteriorhodopsin proteins, but energy densities have so far not reached sufficient levels to be competitive with state-of-the-art photovoltaic cells. For biomedical (e.g., drug delivery) applications the research focus has been on the mechanism of action, and much less on the delivery ‘per se’. Thus, in order for these areas to move forward, we need to address some hard questions: is bacteriorhodopsin really the optimal light harvester to be used in energy conversion? And how do we ensure that biomedical nano-carriers covered with biomimetic membrane material ever reach their target cells/tissue in sufficient quantities? In addition to these area-specific questions the general issue of production cost and scalability must also be treated in order to ensure efficient translation of biomimetic membrane concepts into reality.
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje